Time Frame Future Resist Foundation Broad Spectrum SPF 20 Truffle

Manufacturer: Delilah Cosmetics | Gotha Cosmetics SRL
Effective date: 2015-04-27
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-05-31 22:42:24

Label at a glance#

ProductTime Frame Future Resist Foundation Broad Spectrum SPF 20 Truffle Delilah Cosmetics

Active ingredientAVOBENZONE, OCTINOXATE, OCTOCRYLENE

Label structure2 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients Purpose

Avobenzone 0.6% Sunscreen

Octinoxate 3% Sunscreen

Octocrylene 3% Sunscreen

OTC - PURPOSE SECTION

Uses

Helps prevent Sunburn

If used as directed with other sun protection measures (see Directions), decrease the risk of skin cancer and early skin aging caused by the sun.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

Stop use and ask a dcotor if rash occurs.

WARNINGS SECTION

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

DOSAGE & ADMINISTRATION SECTION

Directions

Apply foundation liberally to clean face for Broad Spectrum protection. Reapply as needed.

This is not a primary Sunscreen. For further protection by a primary Sunscreen follow directions below.

Apply primary Sunscreen liberally 15 minutes before sun exposure

Reapply at least every 2 hours.

Sun Protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF 15 or higher and other sun protection measures including:

Limit time in the sun, especially 10 a.m. - 2 p.m.

Wear long-sleeve shirts, pants, hats, and sunglasses

Children under 6 months ask doctor

INACTIVE INGREDIENT SECTION

Caprylic/Capric TriglycerideInactive Ingredients: Water/Aqua, Cyclomethicone, Butyloctyl Salicylate, Butylene Glycol, Hydrogenated Polyisobutene, Cetyl PEG/PPG-10/1 Dimethicone, Titanium Dioxide, Caprylic/Capric Triglyceride, Isoamyl Laurate, Glyceryl Tribehenate/Isostearate/Eicosadioate, Polymethyl Methacrylate, Isopentyldiol, Lauryl PEG-8 Dimethicone, Phenoxyethanol, Sucrose Acetate Isobutyrate Sodium Chloride, Disteardimonium Hectorite, Polyglyceryl-4-Isostearate, Stearalkonium Hectorite, Triethoxycaprylylsilane, Sodium Dehydroacetate, Tocopheryl Acetate, Propylene Carbonate, Alumina, Trisodium Ethylenediamine Dissucinate, Tropolone, Tripeptide-3, Hexapeptide-3 [May Contain (+/-): CI 77491 (Iron Oxides), CI 77492 (Iron Oxide), CI 77499 (Iron Oxides)].

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

delilah

Time Frame

Future Resist Foundation Broad Spectrum SPF 20 Truffle

Fond de Teint SPF 20

Anti Vieillissement

Foundation Sunscreen

1.28 Fl Oz/ 38 ml

secondary

primary

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69000-011-02	2020-01-31	C162847	48780-1	9d75b9d0-7192-f424-e053-dadaa90a57ce	Future resist Foundation Broad Spectrum SPF 20 Truffle

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
69000-011-01	Time Frame Future Resist Foundation Broad Spectrum SPF 20 TruffleDelilah Cosmetics	38 mL in 1 TUBE	SOLUTION	38		8
69000-011-02	Time Frame Future Resist Foundation Broad Spectrum SPF 20 TruffleDelilah Cosmetics	1 in 1 CARTON	SOLUTION	1		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69000-011	TIME FRAME FUTURE RESIST FOUNDATION BROAD SPECTRUM SPF 20 TRUFFLE DELILAH COSMETICS (AVOBENZONE, OCTINOXATE, OCTOCRYLENE) SOLUTION [DELILAH COSMETICS]	8	Legacy NDC, 2 package rows	20150428_6d1d5452-721c-4939-bb3f-8ff8cbeab510.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	8
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	8
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	8
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	8
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	8
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	8
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	8
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	8
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	8
BUTYLOCTYL SALICYLATE	INACTIVE INGREDIENT	2EH13UN8D3	8
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)	INACTIVE INGREDIENT	V2W71V8T0X	8
CYCLOMETHICONE	INACTIVE INGREDIENT	NMQ347994Z	8
DISTEARDIMONIUM HECTORITE	INACTIVE INGREDIENT	X687XDK09L	8
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	8
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	8
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	8
GLYCERYL TRIBEHENATE/ISOSTEARATE/EICOSANDIOATE	INACTIVE INGREDIENT	3Y9NJ5Z7E5	8
HYDROGENATED POLYBUTENE (1300 MW)	INACTIVE INGREDIENT	7D1YQ9Y5EZ	8
ISOAMYL LAURATE	INACTIVE INGREDIENT	M1SLX00M3M	8
ISOPENTYLDIOL	INACTIVE INGREDIENT	19NOL5474Q	8
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	8
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	8
POLY(METHYL METHACRYLATE; 450000 MW)	INACTIVE INGREDIENT	Z47NNT4J11	8
POLYGLYCERYL-4 ISOSTEARATE	INACTIVE INGREDIENT	820DPX33S7	8
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	8
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	8
SODIUM DEHYDROACETATE	INACTIVE INGREDIENT	8W46YN971G	8
STEARALKONIUM HECTORITE	INACTIVE INGREDIENT	OLX698AH5P	8
SUCROSE ACETATE ISOBUTYRATE	INACTIVE INGREDIENT	H5KI1C3YTV	8
TRIETHOXYCAPRYLYLSILANE	INACTIVE INGREDIENT	LDC331P08E	8
TROPOLONE	INACTIVE INGREDIENT	7L6DL16P1T	8
WATER	INACTIVE INGREDIENT	059QF0KO0R	8

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 31 matching rows.

Time Frame Future Resist Foundation Broad Spectrum SPF 20 Truffle Delilah Cosmetics
Avobenzone, Octinoxate, Octocrylene
AVOBENZONE
OCTINOXATE
OCTOCRYLENE
WATER
CYCLOMETHICONE
BUTYLOCTYL SALICYLATE
BUTYLENE GLYCOL
HYDROGENATED POLYBUTENE (1300 MW)
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)
MEDIUM-CHAIN TRIGLYCERIDES
ISOAMYL LAURATE
GLYCERYL TRIBEHENATE/ISOSTEARATE/EICOSANDIOATE
POLY(METHYL METHACRYLATE; 450000 MW)
ISOPENTYLDIOL
PHENOXYETHANOL
SUCROSE ACETATE ISOBUTYRATE
SODIUM CHLORIDE
DISTEARDIMONIUM HECTORITE
POLYGLYCERYL-4 ISOSTEARATE
STEARALKONIUM HECTORITE
TRIETHOXYCAPRYLYLSILANE
SODIUM DEHYDROACETATE
.ALPHA.-TOCOPHEROL ACETATE
PROPYLENE CARBONATE
ALUMINUM OXIDE
TROPOLONE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
69000-011	69000-011-01, 69000-011-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 29 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
AVOBENZONE	G63QQF2NOX	ACTIB
OCTINOXATE	4Y5P7MUD51	ACTIB
OCTOCRYLENE	5A68WGF6WM	ACTIB
WATER	059QF0KO0R	IACT
CYCLOMETHICONE	NMQ347994Z	IACT
BUTYLOCTYL SALICYLATE	2EH13UN8D3	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
HYDROGENATED POLYBUTENE (1300 MW)	7D1YQ9Y5EZ	IACT
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)	V2W71V8T0X	IACT
MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	IACT
ISOAMYL LAURATE	M1SLX00M3M	IACT
GLYCERYL TRIBEHENATE/ISOSTEARATE/EICOSANDIOATE	3Y9NJ5Z7E5	IACT
POLY(METHYL METHACRYLATE; 450000 MW)	Z47NNT4J11	IACT
ISOPENTYLDIOL	19NOL5474Q	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
SUCROSE ACETATE ISOBUTYRATE	H5KI1C3YTV	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
DISTEARDIMONIUM HECTORITE	X687XDK09L	IACT
POLYGLYCERYL-4 ISOSTEARATE	820DPX33S7	IACT
STEARALKONIUM HECTORITE	OLX698AH5P	IACT
TRIETHOXYCAPRYLYLSILANE	LDC331P08E	IACT
SODIUM DEHYDROACETATE	8W46YN971G	IACT
.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	IACT
PROPYLENE CARBONATE	8D08K3S51E	IACT
ALUMINUM OXIDE	LMI26O6933	IACT
TROPOLONE	7L6DL16P1T	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
FERRIC OXIDE YELLOW	EX438O2MRT	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 222 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / PARENTERAL		210 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUPPOSITORY / RECTAL		140 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRAVASCULAR	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	INJECTION, EMULSION / INTRAVENOUS	1.1 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / TOPICAL	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRATHECAL		9 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INFILTRATION		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / SUBARACHNOID	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / SUBMUCOSAL		17 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	CAPSULE / ORAL		6 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / SUBCUTANEOUS	0.8 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	226 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	3.6 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / SUBCUTANEOUS	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / AURICULAR (OTIC)	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LIQUID / INTRAMUSCULAR		17 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	POWDER, FOR SUSPENSION / ORAL	3390 mg/5ml		Exact identifier — unii candidate 18 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	POWDER / TOPICAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / IONTOPHORESIS	0.6 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR		24 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / SUBMUCOSAL	16 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / SUBLINGUAL	1 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	POWDER, DENTIFRICE / DENTAL	0.03 mg/mg		Exact identifier — unii candidate 134 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TRANSDERMAL	8.12 mg		Exact identifier — unii candidate 2 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRAMUSCULAR		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / ENDOTRACHEAL	7.6 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	CAPSULE, EXTENDED RELEASE / ORAL		41 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	DROPS / NASAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRASYNOVIAL		4 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	AEROSOL, FOAM / TOPICAL	10.87 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, COATED PELLETS / ORAL	2 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 20 equally ranked IID candidates
CYCLOMETHICONE	CYCLOMETHICONE	NMQ347994Z	LOTION / TOPICAL		3510 mg	Exact identifier — unii candidate 5 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET / ORAL		231 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / SOFT TISSUE		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / RETROBULBAR		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / ORAL		148 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii candidate 2 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAVASCULAR	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, EXTENDED RELEASE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / INTRAMUSCULAR	9 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / PERIDURAL	8.07 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / ORAL		24 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRADERMAL	7 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / RESPIRATORY (INHALATION)		43 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
CYCLOMETHICONE	CYCLOMETHICONE	NMQ347994Z	SOLUTION / TOPICAL	11.57 %w/v		Exact identifier — unii candidate 5 equally ranked IID candidates
ALUMINUM OXIDE	ALUMINUM OXIDE	LMI26O6933	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 2 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / INFILTRATION		3535 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION/ DROPS / OPHTHALMIC		3 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRALESIONAL		13 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		360 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	POWDER / SUBLINGUAL		2 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / SUBCUTANEOUS		1486 mg	Exact identifier — unii candidate 134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
54ad45b3-f154-47e4-9cc8-fdd4946b457a			6d1d5452-721c-4939-bb3f-8ff8cbeab510	2015-04-27	Warnings	Exact identifier spl id: 54ad45b3-f154-47e4-9cc8-fdd4946b457a spl set id: 6d1d5452-721c-4939-bb3f-8ff8cbeab510

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.